Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Prostatic Neoplasms 13Lymphoma, Large B-Cell, Diffuse 12Burkitt Lymphoma 12Lymphoma, Follicular 8Lymphoma, Non-Hodgkin 6Lymphoma 6Neoplasms 5Prostatic Neoplasms, Castration-Resistant 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, B-Cell 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Plasmablastic Lymphoma 2Lymphoproliferative Disorders 2Lymphoma, T-Cell 2Lymphoma, B-Cell, Marginal Zone 2Triple Negative Breast Neoplasms 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Multiple Myeloma 1Multi-centric Castleman's Disease 1Metastatic Castration-sensitive Prostate Cancer 1Metastatic Castration-resistant Prostate Neoplasms 1Macular dystrophy, corneal type 1 1Lymphoma, Mantle-Cell 1Lymphadenopathy 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Leukemia, Hairy Cell 1

Interventions

Vincristine 2Rituximab 2Prednisone 2Etoposide 2Doxorubicin 2Cyclophosphamide 2liposomal doxorubicin 1etoposide phosphate 1Zidovudine 1Valganciclovir 1Sirolimus 1Nivolumab 1Interferon-alpha 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Bortezomib 1Biological Assay 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphoproliferative Disorders × Prednisone × 30 days × Clear all
NCT00092222 2026-06-05

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
75 enrolled
Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

NCT06954805 2026-05-27

Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

Columbia University

Phase 2 Recruiting
30 enrolled
Lymphoid

Lymphoma, Lymphoproliferative Disorders, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡